Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal-gastric junction

P. Fencl, O. Belohlavek, T. Harustiak, M. Zemanova,

. 2016 ; 41 (11) : 2089-2094.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18011120

Grantová podpora
NT12331 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek
Zdroj

E-zdroje Online Plný text

NLK ProQuest Central od 2000-01-01 do 2017-12-31
Medline Complete (EBSCOhost) od 2016-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 2000-01-01 do 2017-12-31
Health & Medicine (ProQuest) od 2000-01-01 do 2017-12-31

OBJECTIVES: The aim of the analysis was to assess the accuracy of various FDG-PET/CT parameters in staging lymph nodes after neoadjuvant chemotherapy. METHODS: In this prospective study, 74 patients with adenocarcinoma of the esophageal-gastric junction were examined by FDG-PET/CT in the course of their neoadjuvant chemotherapy given before surgical treatment. Data from the final FDG-PET/CT examinations were compared with the histology from the surgical specimens (gold standard). The accuracy was calculated for four FDG-PET/CT parameters: (1) hypermetabolic nodes, (2) large nodes, (3) large-and-medium large nodes, and (4) hypermetabolic or large nodes. RESULTS: In 74 patients, a total of 1540 lymph nodes were obtained by surgery, and these were grouped into 287 regions according to topographic origin. Five hundred and two nodes were imaged by FDG-PET/CT and were grouped into these same regions for comparison. In the analysis, (1) hypermetabolic nodes, (2) large nodes, (3) large-and-medium large nodes, and (4) hypermetabolic or large nodes identified metastases in particular regions with sensitivities of 11.6%, 2.9%, 21.7%, and 13.0%, respectively; specificity was 98.6%, 94.5%, 74.8%, and 93.6%, respectively. The best accuracy of 77.7% reached the parameter of hypermetabolic nodes. Accuracy decreased to 62.0% when also smaller nodes (medium-large) were taken for the parameter of metastases. CONCLUSIONS: FDG-PET/CT proved low sensitivity and high specificity. Low sensitivity was based on low detection rate (32.6%) when compared nodes imaged by FDG-PET/CT to nodes found by surgery, and in inability to detect micrometastases. Sensitivity increased when also medium-large LNs were taken for positive, but specificity and accuracy decreased.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18011120
003      
CZ-PrNML
005      
20181213111648.0
007      
ta
008      
180404s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00261-016-0820-x $2 doi
035    __
$a (PubMed)27405645
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Fencl, Pavel, $u PET Center, Hospital Na Homolce, Roentgenova 2, 150 30, Prague 5, Czech Republic. pavel.fencl@homolka.cz. $d 1946- $7 xx0074214
245    10
$a FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal-gastric junction / $c P. Fencl, O. Belohlavek, T. Harustiak, M. Zemanova,
520    9_
$a OBJECTIVES: The aim of the analysis was to assess the accuracy of various FDG-PET/CT parameters in staging lymph nodes after neoadjuvant chemotherapy. METHODS: In this prospective study, 74 patients with adenocarcinoma of the esophageal-gastric junction were examined by FDG-PET/CT in the course of their neoadjuvant chemotherapy given before surgical treatment. Data from the final FDG-PET/CT examinations were compared with the histology from the surgical specimens (gold standard). The accuracy was calculated for four FDG-PET/CT parameters: (1) hypermetabolic nodes, (2) large nodes, (3) large-and-medium large nodes, and (4) hypermetabolic or large nodes. RESULTS: In 74 patients, a total of 1540 lymph nodes were obtained by surgery, and these were grouped into 287 regions according to topographic origin. Five hundred and two nodes were imaged by FDG-PET/CT and were grouped into these same regions for comparison. In the analysis, (1) hypermetabolic nodes, (2) large nodes, (3) large-and-medium large nodes, and (4) hypermetabolic or large nodes identified metastases in particular regions with sensitivities of 11.6%, 2.9%, 21.7%, and 13.0%, respectively; specificity was 98.6%, 94.5%, 74.8%, and 93.6%, respectively. The best accuracy of 77.7% reached the parameter of hypermetabolic nodes. Accuracy decreased to 62.0% when also smaller nodes (medium-large) were taken for the parameter of metastases. CONCLUSIONS: FDG-PET/CT proved low sensitivity and high specificity. Low sensitivity was based on low detection rate (32.6%) when compared nodes imaged by FDG-PET/CT to nodes found by surgery, and in inability to detect micrometastases. Sensitivity increased when also medium-large LNs were taken for positive, but specificity and accuracy decreased.
650    _2
$a adenokarcinom $x farmakoterapie $x patologie $x chirurgie $7 D000230
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a adjuvantní chemoterapie $7 D017024
650    _2
$a nádory jícnu $x farmakoterapie $x patologie $x chirurgie $7 D004938
650    _2
$a gastroezofageální junkce $x patologie $7 D004943
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fluorodeoxyglukosa F18 $7 D019788
650    _2
$a lidé $7 D006801
650    _2
$a lymfatické metastázy $x diagnostické zobrazování $x patologie $7 D008207
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neoadjuvantní terapie $7 D020360
650    _2
$a staging nádorů $7 D009367
650    12
$a PET/CT $7 D000072078
650    _2
$a prospektivní studie $7 D011446
650    _2
$a radiofarmaka $7 D019275
650    _2
$a senzitivita a specificita $7 D012680
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bělohlávek, Otakar, $u PET Center, Hospital Na Homolce, Roentgenova 2, 150 30, Prague 5, Czech Republic. $d 1964- $7 ola2003188678
700    1_
$a Haruštiak, Tomáš $u 3rd Clinic of Surgery, First Faculty of Medicine, Charles University in Prague and University Hospital Motol, V Uvalu 84, Praha 5, 150 06, Czech Republic. $7 xx0096527
700    1_
$a Zemanová, Milada $u Clinic of Oncology, First Faculty of Medicine, Charles University in Prague and General Teaching Hospital, U Nemocnice 2, Praha 2, 128 08, Czech Republic. $7 xx0060597
773    0_
$w MED00194920 $t Abdominal radiology $x 2366-0058 $g Roč. 41, č. 11 (2016), s. 2089-2094
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27405645 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20181213111814 $b ABA008
999    __
$a ok $b bmc $g 1288605 $s 1007932
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 41 $c 11 $d 2089-2094 $i 2366-0058 $m Abdominal radiology $n Abdom Radiol (NY) $x MED00194920
GRA    __
$a NT12331 $p MZ0
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...